The adhesion function of the sodium channel beta subunit (β1) contributes to cardiac action potential propagation

  1. Rengasayee Veeraraghavan  Is a corresponding author
  2. Gregory S Hoeker
  3. Anita Alvarez-Laviada
  4. Daniel Hoagland
  5. Xiaoping Wan
  6. D Ryan King
  7. Jose Sanchez-Alonso
  8. Chunling Chen
  9. Jane Jourdan
  10. Lori L Isom
  11. Isabelle Deschenes
  12. James Smyth
  13. Julia Gorelik
  14. Steven Poelzing
  15. Robert G Gourdie  Is a corresponding author
  1. Virginia Polytechnic University, United States
  2. Imperial College London, United Kingdom
  3. Case Western Reserve University, United States
  4. University of Michigan Medical School, United States

Abstract

Computational modeling indicates that cardiac conduction may involve ephaptic coupling - intercellular communication involving electrochemical signaling across narrow extracellular clefts between cardiomyocytes. We hypothesized that β1(SCN1B) - mediated adhesion scaffolds trans-activating NaV1.5 (SCN5A) channels within narrow (V1.5. Smart patch clamp (SPC) indicated greater sodium current density (INa) at perinexi, relative to non-junctional sites. A novel, rationally designed peptide, βadp1, potently and selectively inhibited β1-mediated adhesion, in electric cell-substrate impedance sensing studies. βadp1 significantly widened perinexi in guinea pig ventricles, and selectively reduced perinexal INa, but not whole cell INa, in myocyte monolayers. In optical mapping studies, βadp1 precipitated arrhythmogenic conduction slowing. In summary, β1-mediated adhesion at the perinexus facilitates action potential propagation between cardiomyocytes, and may represent a novel target for anti-arrhythmic therapies.

Data availability

The raw data generated in this study is available via Dryad (doi:10.5061/dryad.10351qn). The raw STORM movies are available on request from the corresponding author due to their large size.

The following data sets were generated

Article and author information

Author details

  1. Rengasayee Veeraraghavan

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    For correspondence
    saiv@vt.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8364-2222
  2. Gregory S Hoeker

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Anita Alvarez-Laviada

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Daniel Hoagland

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Xiaoping Wan

    Department of Medicine, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. D Ryan King

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jose Sanchez-Alonso

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Chunling Chen

    Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Jane Jourdan

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Lori L Isom

    Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Isabelle Deschenes

    Department of Medicine, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. James Smyth

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Julia Gorelik

    Department of Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Steven Poelzing

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Robert G Gourdie

    Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States
    For correspondence
    gourdier@vtc.vt.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6021-0796

Funding

National Heart, Lung, and Blood Institute (RO1 HL56728-15A2)

  • Robert G Gourdie

American Heart Association (16SDG29870007)

  • Rengasayee Veeraraghavan

National Heart, Lung, and Blood Institute (R01 HL102298-01A1)

  • Steven Poelzing

National Institutes of Health (R01 HL102298-01A1)

  • James Smyth

National Institutes of Health (R37NS076752)

  • Lori L Isom

National Heart, Lung, and Blood Institute (RO1 HL HL141855-01)

  • Robert G Gourdie

National Heart, Lung, and Blood Institute (RO1 HL HL141855-01)

  • Steven Poelzing

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). All animal study protocols (15-130, 15-134, 12-140) were approved by the Institutional Animal Care and Use Committee at the Virginia Polytechnic University.

Copyright

© 2018, Veeraraghavan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,358
    views
  • 465
    downloads
  • 98
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rengasayee Veeraraghavan
  2. Gregory S Hoeker
  3. Anita Alvarez-Laviada
  4. Daniel Hoagland
  5. Xiaoping Wan
  6. D Ryan King
  7. Jose Sanchez-Alonso
  8. Chunling Chen
  9. Jane Jourdan
  10. Lori L Isom
  11. Isabelle Deschenes
  12. James Smyth
  13. Julia Gorelik
  14. Steven Poelzing
  15. Robert G Gourdie
(2018)
The adhesion function of the sodium channel beta subunit (β1) contributes to cardiac action potential propagation
eLife 7:e37610.
https://doi.org/10.7554/eLife.37610

Share this article

https://doi.org/10.7554/eLife.37610

Further reading

    1. Cell Biology
    Surya Bansi Singh, Shatruhan Singh Rajput ... Deepa Subramanyam
    Research Article

    Aggregation of mutant forms of Huntingtin is the underlying feature of neurodegeneration observed in Huntington's disorder. In addition to neurons, cellular processes in non-neuronal cell types are also shown to be affected. Cells expressing neurodegeneration-associated mutant proteins show altered uptake of ligands, suggestive of impaired endocytosis, in a manner as yet unknown. Using live cell imaging, we show that clathrin-mediated endocytosis (CME) is affected in Drosophila hemocytes and mammalian cells containing Huntingtin aggregates. This is also accompanied by alterations in the organization of the actin cytoskeleton resulting in increased cellular stiffness. Further, we find that Huntingtin aggregates sequester actin and actin-modifying proteins. Overexpression of Hip1 or Arp3 (actin-interacting proteins) could restore CME and cellular stiffness in cells containing Huntingtin aggregates. Neurodegeneration driven by pathogenic Huntingtin was also rescued upon overexpression of either Hip1 or Arp3 in Drosophila. Examination of other pathogenic aggregates revealed that TDP-43 also displayed defective CME, altered actin organization and increased stiffness, similar to pathogenic Huntingtin. Together, our results point to an intimate connection between dysfunctional CME, actin misorganization and increased cellular stiffness caused by alteration in the local intracellular environment by pathogenic aggregates.

    1. Cell Biology
    2. Developmental Biology
    Evgenia Leikina, Jarred M Whitlock ... Leonid Chernomordik
    Research Article

    The bone-resorbing activity of osteoclasts plays a critical role in the life-long remodeling of our bones that is perturbed in many bone loss diseases. Multinucleated osteoclasts are formed by the fusion of precursor cells, and larger cells – generated by an increased number of cell fusion events – have higher resorptive activity. We find that osteoclast fusion and bone resorption are promoted by reactive oxygen species (ROS) signaling and by an unconventional low molecular weight species of La protein, located at the osteoclast surface. Here, we develop the hypothesis that La’s unique regulatory role in osteoclast multinucleation and function is controlled by an ROS switch in La trafficking. Using antibodies that recognize reduced or oxidized species of La, we find that differentiating osteoclasts enrich an oxidized species of La at the cell surface, which is distinct from the reduced La species conventionally localized within cell nuclei. ROS signaling triggers the shift from reduced to oxidized La species, its dephosphorylation and delivery to the surface of osteoclasts, where La promotes multinucleation and resorptive activity. Moreover, intracellular ROS signaling in differentiating osteoclasts oxidizes critical cysteine residues in the C-terminal half of La, producing this unconventional La species that promotes osteoclast fusion. Our findings suggest that redox signaling induces changes in the location and function of La and may represent a promising target for novel skeletal therapies.